Key market opportunities include growth driven by the rise of electric vehicles, industrial OEM applications, and energy ...

MECHANICSBURG — Cristian Pong wasn’t willing to relinquish his other Mid-Penn Conference crown. Pong, a Loyola University ...

In addition to her 500 free gold, Boone helped Cumberland Valley secure a silver medal in the 400-yard freestyle relay in the ...

A decision to return to the state changed his life trajectory, leading him down the path as a competitive athlete.

Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially ...

In the Bemidji High School boys swimming and diving team's regular season finale, the Lumberjacks picked up five wins and the ...

There is no denying it. This is the biggest crisis of Eddie Howe’s 4½-year reign at Newcastle United as his team were booed ...

The Olympic torch relay will end in Milan and Cortina with the lighting of the 2026 Olympics cauldrons. Here's who could do it.

In 2025 alone, the agency issued over 50 oncology approvals([1]) , but the real story is the aggressive pivot toward targeted therapies for high-unmet-need solid tumors. That momentum has accelerated ...

As of Wednesday, January 28, Relay Therapeutics, Inc.’s RLAY share price has dipped by 5.18%, which has investors questioning if this is right time to buy.

MILAN — Valérie Maltais was cursing under her breath.

Relay Therapeutics upgraded to Outperform: zovegalisib PI3Kα breast cancer catalyst, $596M cash to 2029, Phase 3 mid-2026. Click for more on RLAY stock.